A Phase 1, Single and Multiple Ascending Intravenous (IV) Dose Study of Safety, and Pharmacokinetics (PK) of Radezolid (RDZ) in Healthy Subjects

Trial Profile

A Phase 1, Single and Multiple Ascending Intravenous (IV) Dose Study of Safety, and Pharmacokinetics (PK) of Radezolid (RDZ) in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Sep 2012

At a glance

  • Drugs Radezolid (Primary)
  • Indications Bacterial infections
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 15 Sep 2012 New trial record
    • 11 Sep 2012 Results have been presented at ICAAC-2012 according to a Rib-X Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top